Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | NAAA | Q02083 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4364153 | 1.00 | HCAR2 (0.63) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL8376821 | 1.00 | HCAR2 (0.63) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL8379400 | 1.00 | HCAR2 (0.63) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL1245209 | 1.00 | HCAR2 (0.63) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL5239452 | 1.00 | HCAR2 (0.63) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL4369309 | 1.00 | HCAR2 (0.63) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL5238456 | 1.00 | HCAR2 (0.63) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL697992 | 1.00 | HCAR2 (0.63) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL8390518 | 1.00 | HCAR2 (0.63) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL8378847 | 1.00 | HCAR2 (0.63) | HCAR2ATMNAAATSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009019173-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (CH) | 2009-02-12 | — | — | WO | disclosed |
| EP-1055712-B1 | Aqueous ink for ink jet recording | MITSUI CHEMICALS INC (JP) | 2005-02-16 | — | — | EP | disclosed |
| US-6720421-B2 | STORAGE STABILITY: GOOD RAW-STOCK STORABILITY BEFORE RECORDING AND GOOD IMAGE STORABILITY AFTER RECORDING | FUJI PHOTO FILM CO., LTD. (JP) | 2004-04-13 | — | — | US | disclosed |
| US-20030166961-A1 | Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative | FUJI PHOTO FILM CO., LTD. | 2003-09-04 | — | — | US | disclosed |
| EP-0853077-B1 | Process for producing alkyl 3-amino-4-substituted benzoates | SANKIO CHEMICAL CO LTD (JP) | 2003-04-16 | — | — | EP | disclosed |
| US-20020161225-A1 | Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative | FUJI PHOTO FILM CO., LTD. | 2002-10-31 | — | — | US | disclosed |
| EP-1055712-A2 | Aqueous ink for ink jet recording | Mitsui Chemicals, Inc. (JP) | 2000-11-29 | — | — | EP | disclosed |
| US-5986042-A | Cross-linked polymer | MITSUI CHEMICALS, INC. (JP) | 1999-11-16 | — | — | US | disclosed |
| US-5908955-A | 3-AMINO-4-SUBSTITUTED BENZOIC ACID OR AN ALKALI METAL SALT THEREOF IS ALLOWED TO REACT WITH AN ALKYL HALIDE IN THE PRESENCE OF A BASIC CARBONATE | SANKIO CHEMICAL CO., LTD. (JP) | 1999-06-01 | — | — | US | disclosed |
| EP-0856539-A1 | Cross-linked polymer | Mitsui Chemicals, Inc. (JP) | 1998-08-05 | — | — | EP | disclosed |
| EP-0514332-B1 | Bis-phosphites | CIBA GEIGY AG (CH) | 1996-04-17 | — | — | EP | disclosed |
| US-5504082-A | BACTERICIDE FOR HELICOBACTER, ANTIULCER AGENT, GASTRIC ACIDSUPPRESSOR | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1996-04-02 | — | — | US | disclosed |
| EP-0523543-B1 | Chiral piperazine derivatives | HOFFMANN LA ROCHE (CH) | 1996-02-07 | — | — | EP | disclosed |
| EP-0644191-A1 | PYRIDINE COMPOUND AND MEDICINAL USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1995-03-22 | — | — | EP | disclosed |
| EP-0317983-B1 | Silver halide color photographic material | FUJI PHOTO FILM CO LTD (JP) | 1994-06-01 | — | — | EP | disclosed |
| US-5308902-A | Heterocyclic fused ring structures, stabilizers for PVC and polyolefins | CIBA-GEIGY CORPORATION (US) | 1994-05-03 | — | — | US | disclosed |
| EP-0523543-A1 | Chiral piperazine derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1993-01-20 | — | — | EP | disclosed |
| EP-0514332-A1 | Bis-phosphites | CIBA-GEIGY AG (CH) | 1992-11-19 | — | — | EP | disclosed |
| US-5100771-A | SILVER HALIDE COLOR PHOTOGRAPHIC MATERIAL WITH WATER INSOLUBLE ORGANIC SOLVENT SOLUBLE POLYMER | FUJI PHOTO FILM CO., LTD. (JP) | 1992-03-31 | — | — | US | disclosed |
| EP-0317983-A2 | Silver halide color photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1989-05-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166961-A1 | Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative | UROD, ATIC, DDC | HCAR2 1356/4885ATM 2143/4885NAAA 245/4885 |
| US-20020161225-A1 | Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative | UROD, ATIC, DDC | HCAR2 1356/4885ATM 2143/4885NAAA 245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.